Market closed
Enovis Corporation/$ENOV
Enovis shares are trading lower despite reporting Q1 earnings and revenues that surpassed estimates.
16 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Enovis Corporation
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
Ticker
$ENOV
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
7,367
Website
ENOV Metrics
BasicAdvanced
$1.9B
-
-$14.48
-
-
Price and volume
Market cap
$1.9B
52-week high
$49.38
52-week low
$29.32
Average daily volume
1M
Financial strength
Current ratio
2.552
Quick ratio
0.993
Long term debt to equity
54.068
Total debt to equity
54.832
Interest coverage (TTM)
0.99%
Management effectiveness
Return on assets (TTM)
0.94%
Return on equity (TTM)
-27.35%
Valuation
Price to revenue (TTM)
0.86
Price to book
0.72
Price to tangible book (TTM)
-4.11
Price to free cash flow (TTM)
-47.453
Growth
Revenue change (TTM)
18.32%
Earnings per share change (TTM)
858.37%
3-year revenue growth (CAGR)
12.99%
3-year earnings per share growth (CAGR)
124.64%
ENOV News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Enovis Corporation stock?
Enovis Corporation (ENOV) has a market cap of $1.9B as of May 09, 2025.
What is the P/E ratio for Enovis Corporation stock?
The price to earnings (P/E) ratio for Enovis Corporation (ENOV) stock is 0 as of May 09, 2025.
Does Enovis Corporation stock pay dividends?
No, Enovis Corporation (ENOV) stock does not pay dividends to its shareholders as of May 09, 2025.
When is the next Enovis Corporation dividend payment date?
Enovis Corporation (ENOV) stock does not pay dividends to its shareholders.
What is the beta indicator for Enovis Corporation?
Enovis Corporation (ENOV) does not currently have a Beta indicator.